Viewing Study NCT00479856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-29 @ 8:30 PM
Study NCT ID: NCT00479856
Status: TERMINATED
Last Update Posted: 2012-06-05
First Post: 2007-05-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Breast Cancer View
None Neoplasms, Breast View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ErbB1 View
None ErbB2 View
None GW572016 View
None lapatinib View
None Relapsed breast cancer View
None dual tyrosine kinase inhibitor View
None MBC View
None EGFR View
None Her-2/neu View
None FISH amplification View